SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Myhrer T, Mariussen E, Aas P. Neurotoxicology 2018; 65: 144-165.

Affiliation

Norwegian Defence Research Establishment (FFI), Protection and Societal Security Division, P. O. Box 25, NO-2027 Kjeller, Norway. Electronic address: pal.aas@ffi.no.

Copyright

(Copyright © 2018, Elsevier Publishing)

DOI

10.1016/j.neuro.2018.02.009

PMID

29454886

Abstract

Nerve agent-induced seizures can cause varying degrees of neuropathology depending on level of poisoning and duration of seizing. The intention of this review was to validate a novel approach for establishing effective treatment regimens against soman poisoning. Identification of seizure controlling sites in the forebrain of rats poisoned by soman was made by means of lesions, and the anticonvulsive properties of a number of relevant drugs were tested by microinfusions into the identified areas. By using these procedures, procyclidine emerged as the most potent drug. Its potency was confirmed in systemic studies and is further enhanced when combined with levetiracetam. Acute treatment with a combination of HI-6, levetiracetam and procyclidine (procyclidine regimen) can effectively manage supralethal poisoning by any of the classical nerve agents. Extended treatment with the procyclidine regimen is able to terminate residual "silent", local epileptiform activity in the severely poisoned rats. Evident advantages are seen when the same regimen exerts both powerful anticonvulsant and neuroprotectant efficacies. According to the results presented, the new strategy for establishing therapies against soman-induced seizures appears to be valid.

Copyright © 2018 Elsevier B.V. All rights reserved.


Language: en

Keywords

Countermeasures; Nerve agents; Neuropathology; Seizures

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print